Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Current Leases (2018 - 2025)

Historic Current Leases for Cytosorbents (CTSO) over the last 8 years, with Q3 2025 value amounting to $518000.0.

  • Cytosorbents' Current Leases rose 1990.82% to $518000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $518000.0, marking a year-over-year increase of 1990.82%. This contributed to the annual value of $453000.0 for FY2024, which is 2124.1% up from last year.
  • As of Q3 2025, Cytosorbents' Current Leases stood at $518000.0, which was up 1990.82% from $495000.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Current Leases registered a high of $570566.0 during Q4 2021, and its lowest value of $108939.0 during Q4 2022.
  • In the last 5 years, Cytosorbents' Current Leases had a median value of $412067.0 in 2024 and averaged $359651.2.
  • Per our database at Business Quant, Cytosorbents' Current Leases crashed by 8090.69% in 2022 and then soared by 26858.55% in 2024.
  • Cytosorbents' Current Leases (Quarter) stood at $570566.0 in 2021, then tumbled by 80.91% to $108939.0 in 2022, then surged by 242.98% to $373636.0 in 2023, then grew by 21.24% to $453000.0 in 2024, then rose by 14.35% to $518000.0 in 2025.
  • Its Current Leases stands at $518000.0 for Q3 2025, versus $495000.0 for Q2 2025 and $473889.0 for Q1 2025.